Mounjaro (Tirzepatide): Effects, Side Effects, Price and Online Consultation
Need a Mounjaro consultation while staying in Japan?
English inquiries use LINE wording. Eligibility, dose, price and delivery timing are confirmed through online consultation.
Mounjaro (Tirzepatide): Effects, Side Effects, Price and Online Consultation with tables, FAQ and references. Eligibility and dose are decided through medical consultation.
This page is general information. Eligibility and dose are decided by medical consultation.
What Mounjaro is
Mounjaro is the brand name for tirzepatide, a once-weekly injectable medicine that acts on both GIP and GLP-1 receptors. In clinical care it is used under medical supervision, and in weight-management contexts it is discussed because it can reduce appetite, increase satiety and support meaningful weight reduction in many patients.
It is important to understand that Mounjaro is not simply a product to buy. The appropriate dose, continuation, dose escalation and safety monitoring depend on medical history, other medicines, pregnancy or breastfeeding status, digestive symptoms, daily intake and treatment goals.
| Point | Practical meaning |
|---|---|
| Drug class | GIP/GLP-1 receptor agonist |
| Administration | Once-weekly subcutaneous injection |
| Common early effect | Reduced appetite and earlier fullness |
| Important limitation | Effect and tolerability vary by person |
Expected effects and timeline
Many patients first notice that the amount they can eat becomes smaller, snacks become less attractive, or heavy meals feel uncomfortable. Weight change often follows later.
Clinical trials show dose-dependent weight reduction at group level, but a single patient’s course is affected by baseline weight, dose, adherence, protein intake, strength training, sleep, alcohol, constipation and nausea.
| Period | What is often noticed |
|---|---|
| First days to 2 weeks | Appetite and fullness may change |
| 1 to 3 months | Weight trend becomes easier to judge |
| 3 to 6 months | Lifestyle and dose strategy become important |
| Long term | Maintenance planning is essential |
Safety and side effects
The most common problems are gastrointestinal symptoms such as nausea, constipation, diarrhea, abdominal discomfort, appetite reduction and vomiting. These may occur after the first dose or after dose escalation.
Severe abdominal pain, repeated vomiting, dehydration, inability to drink, confusion, fainting, or suspected hypoglycemia should not be managed only by searching online.
| Symptom | Possible first step |
|---|---|
| Mild nausea | Small low-fat meals and hydration |
| Constipation | Fluids, fiber if tolerated, movement |
| Diarrhea | Hydration and avoid dehydration |
| Severe abdominal pain | Seek medical advice promptly |
Price and online consultation flow
AURELIA ONLINE provides self-pay care. Prices vary by dose and duration, and the latest price should be checked on the price page.
The flow is online booking, questionnaire, video consultation, medical decision, payment when applicable, pharmacist counseling and delivery to a Japanese address when possible. Visitors to Japan should check timing and app registration early.
| Step | What happens |
|---|---|
| 1 | Book online |
| 2 | Complete questionnaire and ID upload |
| 3 | Video consultation |
| 4 | Payment and pharmacy counseling |
| 5 | Delivery when appropriate |
FAQ
Is this page a diagnosis?
No. It is general information. Medical decisions require consultation.
Can I ask in English?
Yes. English pages use LINE wording for inquiries when available, and the booking link is kept for consultation.
Where can I confirm prices?
Please check the price page and the consultation process for the latest price.
Related pages
References
- Eli Lilly and Company. MOUNJARO (tirzepatide) Prescribing Information / Medication Guide.
- European Medicines Agency. Mounjaro EPAR Product Information.
- PMDA / 日本イーライリリー. マンジャロ（チルゼパチド）電子添文・インタビューフォーム.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.